Agents comprising midkine or its inhibitor as active ingredient

Details Agents comprising midkine or its inhibitor as active ingredient Agents comprising midkine or its inhibitor as active ingredient

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 31/727 (2006.01) A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61P 19/00 (2006.01)

Patent

CA 2296409

Midkine (MK), which is a retinoic acid-inducible heparin-binding growth factor, enhances neutrophilic migration and exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be used for treating neutrophilic functional disorders or inflammatory diseases.

On décrit des médicaments servant à traiter des troubles fonctionnels ou des maladies inflammatoires neutrophiles, qui contiennent midkine (MK) comme principe actif, laquelle est un facteur de croissance rétinoïque de fixation à l'héparine pouvant être mobilisé par l'acide. On a constaté que ce facteur de croissance pouvait améliorer la migration neutrophile, et existait en forte concentration à l'état inflammatoire. On décrit en outre des inhibiteurs desdits médicaments.

Affiliated with

Also associated with

Rating

Agents comprising midkine or its inhibitor as active ingredient does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents comprising midkine or its inhibitor as active ingredient, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents comprising midkine or its inhibitor as active ingredient will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1627256